首页GMAB • NASDAQ
add
Genmab A/S - ADR
相关资讯
财务信息
损益表
收入
净收入
| (DKK) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 55.40亿 | 17.57% |
经营支出 | 31.48亿 | 6.78% |
净收入 | 12.66亿 | -39.83% |
净利润率 | 22.85 | -48.82% |
每股收益 | 19.81 | 4,177.88% |
息税折旧摊销前利润 | 22.04亿 | 26.09% |
有效税率 | 26.35% | — |
资产负债表
总资产
负债总额
| (DKK) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 173.18亿 | -37.08% |
总资产 | 396.60亿 | 12.55% |
负债总额 | 77.38亿 | 87.54% |
权益总额 | 319.22亿 | — |
发行在外的股份 | 6351.36万 | — |
市净率 | 0.04 | — |
资产回报率 | 13.53% | — |
资本回报率 | 16.33% | — |
现金流
现金净变动
| (DKK) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | 12.66亿 | -39.83% |
来自运营的现金 | 20.33亿 | -0.20% |
投资现金 | 2.24亿 | -77.78% |
融资现金 | -2.76亿 | -1,480.00% |
现金净变动 | 20.11亿 | -40.84% |
自由现金流 | 14.24亿 | 9.09% |
简介
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US. Wikipedia
成立时间
1999
员工数量
2,635
